Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells
Patricia Hernández-López, Eline van Diest, Péter Brázda, Sabine Heijhuurs, Angelo D. Meringa, Lauren Hoorens Van Heyningen, Caterina Riillo, Caroline Schwenzel, Marina Zintchenko, Inez Johanna, Mara J.T. Nicolasen, Astrid Cleven, Thomas A. Kluiver, Rosemary Millen, Jiali Zheng, Froso Karaiskaki, Trudy Straetemans, Hans Clevers, Remco de Bree, Hendrik G. Stunnenberg, Weng Chuan Peng, Jeanine M.L. Roodhart, Susana Minguet, Zsolt Sebestyén, Dennis X. Beringer, Jürgen Kuball
Topics & Concepts
NKG2DChimeric antigen receptorChimera (genetics)T-cell receptorCD8Cancer researchBiologyCell biologyAntigenCytotoxic T cellCancer cellT cellImmunologyImmune systemCancerIn vitroBiochemistryGeneticsGeneCAR-T cell therapy researchImmune Cell Function and InteractionT-cell and B-cell Immunology